Comparison of the efficiency of two short- term agonist protocols with conventional long protocol in women candidate Microinjectio
Phase 3
- Conditions
- Female infertility associated with male factors.Female infertility associated with male factors
- Registration Number
- IRCT201310311760N26
- Lead Sponsor
- Vice chancellor for research,Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
Inclusio criteria:
Healthy women 18 to 40 years; BMI = 20-32; Regular menstrual
Exclusion criteria:
Women PCOs; thyroid disorders, severe endometriosis, those with ovarian or uterine and ovarian pathology; FSH> 15 IU / LI on day 3 of the cycle; POOR RESPONSE; history of hyper stimulation in previous cycles; smokers; Abnormalities of the uterus, ovary-stimulating drugs or diet 2 months ago or the diet
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Laboratory.
- Secondary Outcome Measures
Name Time Method The number of embryos. Timepoint: 14 the next day embryo transfer. Method of measurement: Ultrasound.;The number of high quality embryos. Timepoint: 14 the next day embryo transfer. Method of measurement: Ultrasound.;Total fertility/ET. Timepoint: 14 the next day embryo transfer. Method of measurement: Ultrasound.;The number of abortions performed. Timepoint: After 10 weeks of gestational sac formation. Method of measurement: clinical.;Consists of dominant follicles. Timepoint: 12 -16 day cycle. Method of measurement: Ultrasound.;Of the ampoules used per protocol. Timepoint: Duration of treatment. Method of measurement: clinical.